CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (3,293,070)	$ (6,480,708)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	683,422	641,615
Gain on sale of property and equipment	(6,083)	0
Unrealized gain on change in fair value of warrants classified as a liability	(613,100)	(782,500)
Stock-based compensation	352,352	1,972,835
Change in provision for bad debts	(290,022)	10,000
Change in operating assets and liabilities:
Accounts receivable	1,389,855	206,227
Inventories	236,159	725,965
Prepaid expenses and other current assets and deposits	398,523	(842,071)
Accounts payable and accrued liabilities	(746,495)	472,201
Deferred revenue	(280,259)	112,656
Net cash used in operating activities	(2,168,718)	(3,963,780)
Cash flows from investing activities:
Proceeds from sale of property and equipment	45,000	0
Purchase of property and equipment	(54,339)	(170,217)
Net cash used in investing activities	(9,339)	(170,217)
Cash flows from financing activities:
Net proceeds from issuance of common stock and warrants	0	4,091,833
Net cash provided by financing activities	0	4,091,833
Net decrease in cash, cash equivalents and restricted cash	(2,178,057)	(42,164)
Cash, cash equivalents and restricted cash at beginning of period	15,215,285	6,554,948
Cash, cash equivalents and restricted cash at end of period	13,037,228	6,512,784
Supplemental Disclosures of Cash Flow Information:
Cash paid during period for interest	0	0
Cash paid during period for income taxes	0	0
Non-cash investing and financing activities:
Property and equipment acquired, and included in accounts payable	20,321	76,178
Deemed dividend warrant modifications	0	110,105
Leased assets obtained in exchange for new operating lease liabilities	1,545,916	0
Fair value of warrants issued	0	3,350,400
Issuance of stock options for payment of accrued bonus	$ 0	$ 300,000